Upgrade to SI Premium - Free Trial

Merck (MRK) to Acquire Peloton Therapeutics for $1.05 Billion Upfront, Plus $1.15 Billion Contingent

May 21, 2019 6:45 AM
(Updated - May 21, 2019 6:50 AM EDT)Merck (NYSE: MRK), known as MSD outside the United States and Canada, and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Hot Corp. News Hot M&A Management Comments Mergers and Acquisitions

Next Articles